Ikarian Capital »

Novo Nordisk A/S shares owned by Ikarian Capital

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.3M 150k 55.49

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Novo Nordisk A/S

Citadel Advisors
Capital Research and Management Company - Division 3
Loomis, Sayles and
Susquehanna International
Morgan Stanley
FMR
Franklin Resources
Fisher Investments
Folketrygdfondet
Goldman Sachs Group
Jane Street
Fayez Sarofim & Co
Everett Harris & Co
UBS Group
State Farm Mutual Automobile Insurance Company

View all funds holding Novo Nordisk A/S